down arrow

Cyfuse Biomedical KK

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3311800001
JPY
690.00
7 (1.02%)

Sep 25

TKS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
75.84
28.48
169.04
32.54
5.21
24.21
28.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
75.84
28.48
169.04
32.54
5.21
24.21
28.14
Raw Material Cost
31.11
8.41
80.51
31.03
13.27
10.48
26.90
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.80
5.64
5.34
3.51
2.61
2.81
2.56
Selling and Distribution Expenses
246.31
236.00
226.72
220.25
222.85
254.06
222.56
Other Expenses
-0.58
-0.56
-0.53
-0.35
-0.26
-0.28
-0.26
Total Expenditure (Excl Depreciation)
277.42
244.41
307.23
251.28
236.12
264.55
249.46
Operating Profit (PBDIT) excl Other Income
-201.6
-215.9
-138.2
-218.70000000000002
-230.9
-240.3
-221.29999999999998
Other Income
-2.44
-1.94
17.50
-11.77
-5.36
80.79
16.47
Operating Profit (PBDIT)
-197.85
-211.73
-111.12
-221.32
-227.28
-151.81
-195.54
Interest
5.80
5.64
5.34
3.51
2.61
2.81
2.56
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
44.73
20.07
88.53
1.51
-8.07
13.73
1.24
Depreciation
6.16
6.15
9.57
9.19
9.00
7.73
9.32
Profit Before Tax
-209.81
-223.51
-126.03
-234.03
-238.90
-162.35
-207.42
Tax
0.64
0.64
0.64
0.64
0.64
0.64
0.64
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-210.44
-224.15
-126.66
-234.66
-239.53
-162.99
-208.06
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-210.44
-224.15
-126.66
-234.66
-239.53
-162.99
-208.06
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-210.44
-224.15
-126.66
-234.66
-239.53
-162.99
-208.06
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,622.18
2,747.17
2,757.63
2,857.14
2,330.45
2,394.96
2,542.41
Earnings per share (EPS)
-20.9
-22.56
-13.18
-25.83
-28.96
-19.9
-25.56
Diluted Earnings per share
-20.9
-22.56
-13.18
-25.83
-28.96
-19.9
-25.56
Operating Profit Margin (Excl OI)
-265.78%
-758.22%
-81.75%
-672.22%
-4434.66%
-992.58%
-786.59%
Gross Profit Margin
-268.52%
-763.24%
-68.89%
-690.94%
-4415.08%
-638.6%
-704.06%
PAT Margin
-277.47%
-787.06%
-74.93%
-721.15%
-4600.15%
-673.15%
-739.44%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 1,357.69% vs -28.77% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 12.15% vs -7.45% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 11.94% vs -5.67% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is 123.08% vs 8.33% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of Cyfuse Biomedical KK With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
75.84
170.77
-94.93
-55.59%
Other Operating Income
0.00
0.00
0.00
Total Operating income
75.84
170.77
-94.93
-55.59%
Raw Material Cost
31.11
171.21
-140.10
-81.83%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5.80
0.33
5.47
1,657.58%
Selling and Distribution Expenses
246.31
120.94
125.37
103.66%
Other Expenses
-0.58
16.34
-16.92
-103.55%
Total Expenditure (Excl Depreciation)
277.42
455.91
-178.49
-39.15%
Operating Profit (PBDIT) excl Other Income
-201.57
-285.14
83.57
29.31%
Other Income
-2.44
-2.17
-0.27
-12.44%
Operating Profit (PBDIT)
-197.85
-287.31
89.46
31.14%
Interest
5.80
0.33
5.47
1,657.58%
Exceptional Items
0.00
-0.75
0.75
100.00%
Gross Profit (PBDT)
44.73
-0.44
45.17
10,265.91%
Depreciation
6.16
0.00
6.16
Profit Before Tax
-209.81
-288.39
78.58
27.25%
Tax
0.64
0.54
0.10
18.52%
Provisions and contingencies
0
0
0.00
Profit After Tax
-210.44
-288.94
78.50
27.17%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-210.44
-288.94
78.50
27.17%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-210.44
-288.94
78.50
27.17%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,622.18
2,348.41
273.77
11.66%
Earnings per share (EPS)
-20.90
-0.72
-20.18
-2,802.78%
Diluted Earnings per share
-20.90
-0.72
-20.18
-2,802.78%
Operating Profit Margin (Excl OI)
-265.78%
-166.98%
0.00
-98.80%
Gross Profit Margin
-268.52%
-168.88%
0.00
-99.64%
PAT Margin
-277.47%
-169.20%
0.00
-108.27%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 7.58 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 165.96% vs -83.14% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 1,357.69% vs -28.77% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit -21.04 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 6.11% vs -76.87% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 12.15% vs -7.45% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -19.54 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 6.86% vs -63.14% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 11.94% vs -5.67% in Jun 2025

Quarterly - Interest
Interest 0.58 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 3.57% vs 5.66% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 123.08% vs 8.33% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -265.78%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Footer loading